Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
UBS
McKesson
Dow
AstraZeneca
US Department of Justice
Teva
Mallinckrodt
Merck

Generated: April 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 9,364,485

« Back to Dashboard

Which drugs does patent 9,364,485 protect, and when does it expire?

Patent 9,364,485 protects SERNIVO and is included in one NDA.

This patent has four patent family members in three countries.
Summary for Patent: 9,364,485
Title:Topical formulations comprising a steroid
Abstract: The application provides formulations for the topical administration of an active agent comprising at least one steroid, in the form of topical sprays that are propellant-free, and/or substantially non-foaming, and/or alcohol-free. The present application also provides processes for preparing such compositions and methods of using them in management of skin diseases or disorders such as psoriasis, dermatoses, and other associated skin diseases or disorders.
Inventor(s): Ubaidulla; Udhumansha (Namakkal, IN), Kandavilli; Sateesh (Hyderbad, IN), Vairale; Ajay Sunil (Hyderbad, IN), Wayne; Jeffrey A. (Markham, CA), Nalamothu; Vijendra (Basking Ridge, NJ), Meghal; Mistry (Ahmedabad, IN), Pakunlu; Refika Isil (Highland Park, NJ)
Assignee: DR. REDDY'S LABORATORIES LTD. (Hyderabad, IN)
Application Number:13/391,972
Patent Claim Types:
see list of patent claims
Composition; Use;

Drugs Protected by US Patent 9,364,485

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Promius Pharma Llc SERNIVO betamethasone dipropionate SPRAY;TOPICAL 208079-001 Feb 5, 2016 RX Yes Yes ➤ Sign Up ➤ Sign Up Y TREATMENT OF PLAQUE PSORIASIS ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 9,364,485

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
India2111/CHE/2009Aug 31, 2009
PCT Information
PCT FiledAugust 31, 2010PCT Application Number:PCT/US2010/047240
PCT Publication Date:March 03, 2011PCT Publication Number: WO2011/026076

International Patents Family Members for US Patent 9,364,485

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 2473161 ➤ Sign Up
Japan 2013503203 ➤ Sign Up
Japan 5833007 ➤ Sign Up
World Intellectual Property Organization (WIPO) 2011026076 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Cantor Fitzgerald
QuintilesIMS
Deloitte
AstraZeneca
Citi
Chubb
Cipla
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.